ALLOX

1. 29 Oct 2026

   Seed

   €9.4M

   Cumulative €9.4M

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Hire29 Oct 2026

  ALLOX has appointed Morten Graugaard as Independent Chair of its Board of Directors.

  Independent Chair of the Board of Directors

  ▸Source: Tech.eu

  “Biotechnology company ALLOX has raised$10.5 million in a seed funding round to expand its drug discovery platform andadvance its internal development programmes. The round was led by Asabysthrough…”

  Read at Tech.eu

• Funding29 Oct 2026EUR 9.4M

  Biotechnology company ALLOX has raised $10.5 million in a seed funding round to expand its drug discovery platform and advance its internal development programmes.

  ▸Source: Tech.eu

  “Biotechnology company ALLOX has raised$10.5 million in a seed funding round to expand its drug discovery platform andadvance its internal development programmes. The round was led by Asabysthrough…”

  Read at Tech.eu

• Júlia Domingo

  CEO and co-founder

• Morten Graugaard

  Independent Chair of the Board of Directors

What does ALLOX do?

ALLOX is developing a drug discovery platform that combines high-throughput genetics, experimental biology and artificial intelligence to identify previously unexplored opportunities for developing small-molecule therapeutics.

Where is ALLOX headquartered?

ALLOX is based in Iceland.

How much funding has ALLOX raised?

ALLOX has raised €9.4M (across 1 round · last 29 Oct 2026).

What was ALLOX's latest funding round?

ALLOX's most recent disclosed round was a seed round of €9.4M, announced 29 October 2026.

Who has invested in ALLOX?

Investors in ALLOX include Asabys, CDTI, Institut Català de Finances (ICF).